ADAP
Adaptimmune Therapeutics
ADAP
ADAP
77 hedge funds and large institutions have $1.28B invested in Adaptimmune Therapeutics in 2020 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 11 closing their positions.
Holders
77
Holders Change
+30
Holders Change %
+63.83%
% of All Funds
1.58%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
%
% of All Funds
0.08%
New
41
Increased
19
Reduced
11
Closed
11
Calls
$5.46M
Puts
$10.7M
Net Calls
-$5.23M
Net Calls Change
-$5.3M